Management of Bone Disease and Body Composition Changes
Summary
- Use of the thymidine analogue NRTIs that are associated with lipoatrophy has waned in favor of NRTIs that are more tolerable, such as tenofovir DF, abacavir, and tenofovir AF
- Many clinicians agree that prevention of lipoatrophy is a better practice than trying to reverse the process once it is clinically evident
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content